TFFP - TFF Pharmaceuticals, Inc. Quarterly EPS earnings growth
The platform's macro-resilience and independence from GDP guarantee the reliability of TFF Pharmaceuticals (TFFP) assets. The quarterly trend of EPS growth confirms these theses, with the indicator holding at 64.80. Innovations in thin-film freezing of powders simplify drug logistics; however, the current liquidation of patents and the cessation of operating activities create serious risks for investors.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_TFFP_-_TFF-Pharmaceuticals_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "tffpharma.com (TFFP): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 12/21/2024 | 👁️GURU.Markets👁️")
Analytical breakdowns for TFF Pharmaceuticals, Inc (TFFP)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital TFF Pharmaceuticals|TFFP - Long-Term Liabilities to Equity|Short-Term Debt to Capital TFF Pharmaceuticals|TFFP - Company Aggregate Indebtedness|Debt to Book Value TFF Pharma|TFFP - Company Long-Term Loans and Borrowings|Company Short-Term Debt TFF Pharmaceuticals|Quick Ratio tffpharma.com
- earnings and market multiples details:
TFFP - Final Profit|Projected Future Earnings TFF Pharmaceuticals|TFFP - P/E Multiple|Future Price to Earnings TFF Pharma|TFFP - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TFF Pharma|TFFP - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) TFF Pharmaceuticals|TFFP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth tffpharma.com|TFFP - Net earnings per share growth this year|Earnings growth forecast for next year TFF Pharmaceuticals
- sales revenue and business income indicators:
General company analysis:TFF Pharmaceuticals, Inc., TFFP
Licensing of thin-film freezing technology for powder inhalers provides TFF Pharmaceuticals (TFFP) with a long-term royalty stream. By analyzing EPS dynamics over a quarterly period, an investor assesses the percentage growth of net income per share relative to the previous quarter, which allows them to filter out market noise and determine the true value of the business while avoiding the dangerous traps of falling-knife assets.
Who TFF Pharmaceuticals competes with
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Perrigo - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ALVO (Alvotech S.A.)|Liquidia Technologies - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months GLPG|ANIP: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months MNKD (mannkindcorp.com)|Year-over-year net earnings per share growth for the last 12 months AMPH|PCRX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|TBPH: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic - Quarterly EPS earnings growth|TNXP - Quarterly EPS earnings growth|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Eupraxia Pharmaceuticals Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences|Year-over-year net earnings per share growth for the last 12 months invizyne.com (EXOZ)|Quarterly EPS earnings growth ORMP|Quarterly EPS earnings growth enterabio.com (ENTX)|Quarterly EPS earnings growth HYFT (MindWalk)|ABVC - Year-over-year net earnings per share growth for the last 12 months|Cumberland Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months quantumbiopharma.com|FGEN (FibroGen) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Inc (TELO) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RANI|SNYR (Synergy CHC Corporation) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth RLYB|Year-over-year net earnings per share change for the last twelve months lexariabioscience.com|Quarterly EPS earnings growth PULM (Pulmatrix)|PTHL - Year-over-year net earnings per share growth for the last 12 months|Aptorum - Quarterly EPS earnings growth|LYRA - Quarterly EPS earnings growth|Impact BioMedical (IBO) - Year-over-year earnings per share growth for the last twelve months|TNFA (TNF Pharmaceuticals, Inc.) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months cbdMD Inc.|PainReform Ltd (PRFX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CYTO (Altamira Therapeutics)|Year-over-year earnings per share growth rate for the last twelve months LIPO|Quarterly EPS earnings growth OPTN (OptiNose, Inc.)|PIRS (pieris.com) - Year-over-year net earnings per share trend for the last twelve months|Procaps - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months PTPI|Qilian International Holding Group Limited (QLI) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SLRN (ACELYRIN Inc.)
